Inflammatory Markers Predicting Pathological Complete Response in Cases with Breast Cancer Treated by Neoadjuvant Chemotherapy | Zendy

Mahmut Büyükşimşek | Zendy; Ali Oğul | Zendy; Cem Mirilli | Zendy; Semra Paydaş | Zendy

Open Access

Inflammatory Markers Predicting Pathological Complete Response in Cases with Breast Cancer Treated by Neoadjuvant Chemotherapy

Author(s) -

Mahmut Büyükşimşek,

Ali Oğul,

Cem Mirilli,

Semra Paydaş

Publication year - 2020

Publication title -

meme sağlığı dergisi/meme sağlığı dergisi

Language(s) - English

Resource type - Journals

eISSN - 1306-0953

pISSN - 1306-0945

DOI - 10.5152/ejbh.2020.5556

Subject(s) - medicine , receiver operating characteristic , breast cancer , gastroenterology , logistic regression , neutrophil to lymphocyte ratio , odds ratio , lymphocyte , cancer , oncology

Response to neoadjuvant chemotherapy (NAC) is predictive for survival times in some patients with breast cancer (BC). The aim of this study is to explore the predictive value of some inflammatory markers including neutrophil-to-lymphocyte ratio (NLR), derived neutrophil-to-lymphocyte ratio (dNLR), monocyte-to-high density lipoprotein ratio (MHR) and prognostic nutritional index (PNI) in cases with BC treated with NAC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research